Mainstay Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Mainstay Capital Management's LLY Position: Q1 2026 in Review
Mainstay Capital Management increased its Eli Lilly (LLY) stake by 3.5% in Q1 2026, buying an estimated $55.8K and bringing the position to 1,618 shares worth $1.49M. The position accounts for 0.11% of the portfolio, ranked #55.
Mainstay Capital Management first reported a position in LLY in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.3M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Mainstay Capital Management held 1,618 shares of Eli Lilly worth $1.49M as of Q1 2026.
- Mainstay Capital Management bought 55 Eli Lilly shares in Q1 2026, an estimated $55.8K.
- Eli Lilly made up 0.11% of Mainstay Capital Management's portfolio in Q1 2026, its #55 holding.
- Mainstay Capital Management first reported a position in Eli Lilly in Q4 2017 and has held it in 15 quarters since.
- Mainstay Capital Management's Eli Lilly position peaked at $2.3M in Q2 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Mainstay Capital Management's 13F filing for Q1 2026, filed 12 May 2026.